Literature DB >> 16521258

Impact of medical complications on outcome after subarachnoid hemorrhage.

Katja E Wartenberg1, J Michael Schmidt, Jan Claassen, Richard E Temes, Jennifer A Frontera, Noeleen Ostapkovich, Augusto Parra, E Sander Connolly, Stephan A Mayer.   

Abstract

OBJECTIVE: Medical complications occur frequently after subarachnoid hemorrhage (SAH). Their impact on outcome remains poorly defined.
DESIGN: Inception cohort study. PATIENTS: Five-hundred eighty patients enrolled in the Columbia University SAH Outcomes Project between July 1996 and May 2002.
SETTING: Neurologic intensive care unit.
INTERVENTIONS: Patients were treated according to standard management protocols.
MEASUREMENTS AND MAIN RESULTS: Poor outcome was defined as death or severe disability (modified Rankin score, 4-6) at 3 months. We calculated the frequency of medical complications according to prespecified criteria and evaluated their impact on outcome, using forward stepwise multiple logistic regression after adjusting for known predictors of poor outcome. Thirty-eight% had a poor outcome; mortality was 21%. The most frequent complications were temperature>38.3 degreesC (54%), followed by anemia treated with transfusion (36%), hyperglycemia>11.1 mmol/L (30%), treated hypertension (>160 mm Hg systolic; 27%), hypernatremia>150 mmol/L (22%), pneumonia (20%), hypotension (<90 mm Hg systolic) treated with vasopressors (18%), pulmonary edema (14%), and hyponatremia<130 mmol/L (14%). Fever (odds ratio [OR], 2.0; 95% confidence interval [CI], 1.1-3.4; p=.02), anemia (OR, 1.8; 95% CI, 1.1-2.9; p=.02), and hyperglycemia (OR, 1.8; 95% CI, 1.1-3.0; p=.02) significantly predicted poor outcome after adjustment for age, Hunt-Hess grade, aneurysm size, rebleeding, and cerebral infarction due to vasospasm.
CONCLUSIONS: Fever, anemia, and hyperglycemia affect 30% to 54% of patients with SAH and are significantly associated with mortality and poor functional outcome. Critical care strategies directed at maintaining normothermia, normoglycemia, and prevention of anemia may improve outcome after SAH.

Entities:  

Mesh:

Year:  2006        PMID: 16521258     DOI: 10.1097/01.ccm.0000201903.46435.35

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  161 in total

Review 1.  Therapeutic hypothermia for acute neurological injuries.

Authors:  Lucia Rivera-Lara; Jiaying Zhang; Susanne Muehlschlegel
Journal:  Neurotherapeutics       Date:  2012-01       Impact factor: 7.620

2.  The risks of blood transfusion in patients with subarachnoid hemorrhage.

Authors:  Paul E Marik
Journal:  Neurocrit Care       Date:  2012-04       Impact factor: 3.210

3.  Intensive versus conventional insulin therapy in critically ill neurologic patients: still searching for the sweet spot.

Authors:  Jennifer A Frontera
Journal:  Neurocrit Care       Date:  2010-12       Impact factor: 3.210

Review 4.  Brain-lung crosstalk: Implications for neurocritical care patients.

Authors:  Ségolène Mrozek; Jean-Michel Constantin; Thomas Geeraerts
Journal:  World J Crit Care Med       Date:  2015-08-04

5.  The Role of Platelet Activation and Inflammation in Early Brain Injury Following Subarachnoid Hemorrhage.

Authors:  Jennifer A Frontera; J Javier Provencio; Fatima A Sehba; Thomas M McIntyre; Amy S Nowacki; Errol Gordon; Jonathan M Weimer; Louis Aledort
Journal:  Neurocrit Care       Date:  2017-02       Impact factor: 3.210

6.  Free Fatty acids and delayed cerebral ischemia after subarachnoid hemorrhage.

Authors:  Neeraj Badjatia; David Seres; Amanda Carpenter; J Michael Schmidt; Kiwon Lee; Stephan A Mayer; Jan Claassen; E Sander Connolly; Mitchell S Elkind
Journal:  Stroke       Date:  2012-01-26       Impact factor: 7.914

Review 7.  Effect of pharmaceutical treatment on vasospasm, delayed cerebral ischemia, and clinical outcome in patients with aneurysmal subarachnoid hemorrhage: a systematic review and meta-analysis.

Authors:  Nima Etminan; Mervyn D I Vergouwen; Don Ilodigwe; R Loch Macdonald
Journal:  J Cereb Blood Flow Metab       Date:  2011-02-02       Impact factor: 6.200

8.  Brain natriuretic peptide concentrations after aneurysmal subarachnoid hemorrhage: relationship with hypovolemia and hyponatremia.

Authors:  Sanne M Dorhout Mees; Reinier G Hoff; Gabriel J E Rinkel; Ale Algra; Walter M van den Bergh
Journal:  Neurocrit Care       Date:  2011-04       Impact factor: 3.210

9.  Implications of early versus late bilateral pulmonary infiltrates in patients with aneurysmal subarachnoid hemorrhage.

Authors:  Andreas H Kramer; Thomas P Bleck; Aaron S Dumont; Neal F Kassell; Claire Olson; Bart Nathan
Journal:  Neurocrit Care       Date:  2008-09-23       Impact factor: 3.210

10.  Factors associated with the development of anemia after subarachnoid hemorrhage.

Authors:  Tomoko R Sampson; Rajat Dhar; Michael N Diringer
Journal:  Neurocrit Care       Date:  2009-09-24       Impact factor: 3.210

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.